crohn-s-disease

Documents about crohn-s-disease

• A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis#884547ClinicalTrials.gov
• Revolutionizing Crohn’s disease detection: integrating AI with intestinal ultrasound for superior diagnosis.#196051NCBI PubMed Central
• Epigenetic modulation of stromal cell states underpins pathological tissue niches in Crohn’s disease#676892HAL (France)
• The NOR-SWITCH Study#847677ClinicalTrials.gov
• SMART-IBD App Trial#862212ClinicalTrials.gov
• Attentional variability as a cognitive marker of clinical activity in Crohn's disease.#1039935NCBI PubMed Central
• Individualized Infiximab Dosing-Proof of Concept Study#915974ClinicalTrials.gov
• Etude du dysfonctionnement des macrophages de patients atteints de maladie de Crohn vis-à-vis de l'infection par les bactéries Escherichia coli adhérentes et invasives#670236HAL (France)
• Micro- and Nanoplastics: A Paradigm Shift in the Pathogenesis of Inflammatory Bowel Disease#396644ODU Digital Commons
• Efficacy and Safety of Vedolizumab in Biologic-naïve Korean Patients With Moderate to Severe Inflammatory Bowel Disease#908287ClinicalTrials.gov
• Scrolling for science: Assessing the quality and accuracy of Crohn’s disease-related content on Instagram reels.#288940NCBI PubMed Central
• Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease#893722ClinicalTrials.gov
• A Brief Intervention to Improve Adherence in Teens With Inflammatory Bowel Disease#917284ClinicalTrials.gov
• Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic#807054ClinicalTrials.gov
• Impaired Insulin-like Growth Factor-1 (IGF-1) Generation Causes Protein Catabolism and Poor Growth in Children With Crohn Disease#834403ClinicalTrials.gov
• Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowel Disease in Belgium#841212ClinicalTrials.gov
• Multimodal Approach in IBD Patients#879936ClinicalTrials.gov
• Bayesian prior elicitation on the efficacy of medical therapies in perianal fistulizing Crohn’s disease#219325Ora Oxford University Research
• Supplementary Material for: From Orofacial Granulomatosis to Crohn’s Disease: A Case Report#294273Figshare
• Glucocorticoid-induced Osteopenia in Children#806341ClinicalTrials.gov
• Effect of a Comprehensive Nutrition Support Product on the Nutritional Status of Adults With Inflammatory Bowel Disease#845236ClinicalTrials.gov
• Home Versus Postal Testing for Faecal Calprotectin: a Feasibility Study#800297ClinicalTrials.gov
• The GETAID: over 40 years of academic research in IBD#156303HAL (France)
• Inflammatory Bowel Disease Patients’ Perspectives of Clinical Trials: A Global Quantitative and Qualitative Analysis#288104HAL (France)
• A Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's Disease#839307ClinicalTrials.gov
• Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety#842466ClinicalTrials.gov
• Long-term Treatment With Ustekinumab in Patients With Crohn's Disease and Ulcerative Colitis: a Cohort Study#862554ClinicalTrials.gov
• Perturbations of diet and gut signatures persist during remission in Crohn’s Disease despite effective immune suppression#376076PubMed Central
• From preclinical phase of Crohn's disease to postoperative recurrence: shared mechanisms and potential interventions.#388787NCBI PubMed Central
• Salvage Therapy With High/Low Methotrexate for Loss of Response to Infliximab Dose Escalation#869781ClinicalTrials.gov
• A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Patients With Crohn's Disease#845741ClinicalTrials.gov
• Observational Study Evaluating the Effectiveness of Drug Concentration to Predict the Recapture of Response in Crohn's Disease Patients With Loss of Response ( PRADA )#852154ClinicalTrials.gov
• The Value of I-Scan and Confocal Laser Endomicroscopy for the Assessment of Chronic Inflammatory Bowel Disease#867114ClinicalTrials.gov
• Enabling Microbiomics- Driven Personalized Nutrition#916640ClinicalTrials.gov
• Fecal metaproteomics enables functional characterization of remission in patients with inflammatory bowel disease#965609Bielefeld Pub
• A Mindfulness-based Stress Reduction Program for IBD#863839ClinicalTrials.gov
• Treatment of Moderate to Severe Refractory Crohn's Disease#890781ClinicalTrials.gov
• Integrating inflammatory and coagulation biomarkers for surgical risk stratification and treatment benefit assessment in Crohn’s disease.#218949NCBI PubMed Central
• Disrupted oral microbial networks and reproducible community signatures implicate the oral-gut axis in Crohn's disease#234344bioRxiv / medRxiv
• Gut Lactate Boosts Ruminococcus via Histone Lactylation to Mediate Time-Restricted Feeding Protection in Crohn's Disease.#284948NCBI PubMed Central
• High thrombin activity associated with crohn's disease induces microbiota pathogenicity contributing to mucosal inflammation.#305204NCBI PubMed Central
• Protein language models uncover carbohydrate-active enzyme function in metagenomics.#337073Apollo
• Comparative Safety of Ustekinumab and Vedolizumab in Older Patients with Inflammatory Bowel Disease: A Bicentric Cohort Study#643019HAL (France)
• A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real-World Practice#850573ClinicalTrials.gov
• OTIS Cimzia Pregnancy Registry#865657ClinicalTrials.gov
• Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease#887723ClinicalTrials.gov
• Semi‐Automatic Assessment of Crohn's Disease Activity by Combined Analysis of Bowel Lesions and Creeping Fat#195862HAL (France)
• Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn’s Disease#308229HAL (France)
• Shared genetic architecture between Crohn's disease and IgA nephropathy: implications for a gut-immune-kidney axis.#469250NCBI PubMed Central
• Exploring the impact of DEP on pediatric Crohn's disease using machine learning and molecular docking methods.#636361NCBI PubMed Central